To better characterize the factors secreted by MSC-EM, we used the Bio-Plex ProTM Human Cytokine 27-plex Assay to analyze the secretome of early (initial MSC-EM, 14 days post-UCP preparation) and late (MSC-EM, 2 months post-UCP preparation) induced MSC-EMs upon activation with IFN-γ and TNF-α. The gene discussed is IFNG; the disease is undifferentiated pancreatic carcinoma.